Pausing cancer screening during the SARS-CoV-2 pandemic: should we revisit the recommendations?

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, China in late 2019, has become a major concern all over the world. By March 11, 2020, the number of cases of SARS-CoV-2 infection outside China had increased 13-fold, and the number of affected countries had tripled. With more than 118,000 people affected by the virus worldwide and 4,291 deaths, the World Health Organization announced that the outbreak of coronavirus disease 2019 (COVID-19) was a pandemic.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Letter to the Editor Source Type: research